Your browser doesn't support javascript.
loading
Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.
Lavaud, Pernelle; Gravis, Gwenaëlle; Foulon, Stéphanie; Joly, Florence; Oudard, Stéphane; Priou, Frank; Latorzeff, Igor; Mourey, Loïc; Soulié, Michel; Delva, Remy; Krakowski, Ivan; Laguerre, Brigitte; Théodore, Christine; Ferrero, Jean Marc; Beuzeboc, Philippe; Habibian, Muriel; Rolland, Frédéric; Deplanque, Gael; Pouessel, Damien; Zanetta, Sylvie; Berdah, Jean François; Dauba, Jerome; Baciuchka, Marjorie; Platini, Christian; Linassier, Claude; Tubiana-Mathieu, Nicole; Machiels, Jean Pascal; Kouri, Claude El; Ravaud, Alain; Suc, Etienne; Eymard, Jean Christophe; Hasbini, Ali; Bousquet, Guilhem; Culine, Stéphane; Boher, Jean-Marie; Tergemina-Clain, Gabrielle; Legoupil, Clémence; Fizazi, Karim.
Afiliación
  • Lavaud P; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Gravis G; Institut Paoli Calmette, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS, UMR7258, Marseille University, UM 105, F-13284, Marseille, France.
  • Foulon S; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France.
  • Joly F; Oncology Department, Centre François Baclesse, Caen, France.
  • Oudard S; Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France.
  • Priou F; Department of Oncology, Centre hospitalier départemental Les Oudairies, La Roche-sur-Yon, France.
  • Latorzeff I; Department of Radiotherapy, Groupe ONCORAD Garonne and Clinique Pasteur, Toulouse, France.
  • Mourey L; Department of Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Soulié M; Department of Urology, Andrology and Transplantation, Centre Hospitalier Universitaire Toulouse-Rangueil, Toulouse, France.
  • Delva R; Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France.
  • Krakowski I; Department of Oncology, Centre Bergonié, Bordeaux, France.
  • Laguerre B; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Théodore C; Department of Medical Oncology, Hopital Foch, Suresnes, France.
  • Ferrero JM; Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France.
  • Beuzeboc P; Department of Medical Oncology, Curie Institute, Paris, France.
  • Habibian M; R&D Unicancer, Paris, France.
  • Rolland F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint Herblain, France.
  • Deplanque G; Department of Medical Oncology, Hopital Riviera-Chablais, Vaud-Valais - Vevey, Switzerland.
  • Pouessel D; Department of Medical Oncology, Institut Claudius Rigaud, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France.
  • Zanetta S; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France.
  • Berdah JF; Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France.
  • Dauba J; Medical Oncology Department, Hôpital Layné, Mont de Marsan, France.
  • Baciuchka M; Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France.
  • Platini C; Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France.
  • Linassier C; Medical Oncology Department, Hôpital Bretonneau, Tours, France.
  • Tubiana-Mathieu N; Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France.
  • Machiels JP; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium.
  • Kouri CE; Medical Oncology Department, Centre Catherine de Sienne, Nantes, France.
  • Ravaud A; Medical Oncology Department, Hôpital Saint-André, Bordeaux, France.
  • Suc E; Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France.
  • Eymard JC; Medical Oncology Department, Institut Jean Godinot, Reims, France.
  • Hasbini A; Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint Brieuc, France.
  • Bousquet G; Medical Oncology Department, Hôpital Avicenne, Bobigny, France.
  • Culine S; Medical Oncology Department, Hôpital Saint Louis, Paris, France.
  • Boher JM; Department of Clinical Research and Investigation, Biostatistics, and Methodology Unit, Institut Paoli Calmettes, Marseille, France.
  • Tergemina-Clain G; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France.
  • Legoupil C; Department of Clinical Research and Investigation, Biostatistics and Methodology Unit, Institut Gustave Roussy, Villejuif, France.
  • Fizazi K; Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.
Eur Urol ; 73(5): 696-703, 2018 05.
Article en En | MEDLINE | ID: mdl-29074061
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antagonistas de Andrógenos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Aged / Aged80 / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur Urol Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antagonistas de Andrógenos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Aged / Aged80 / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur Urol Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza